Magenta Therapeutics
Magenta Therapeutics is a biotechnology company using stem cells to develop cellular therapies for immune and blood-based diseases.
3
Funding Rounds
$150.5m
Money raised
Overview
Magenta Therapeutics is a biotechnology company using stem cells to develop cellular therapies for immune and blood-based diseases.
-
Website:
- Business model: B2B
- Social accounts:
Funding series
Funding Series Analysis
The company Magenta Therapeutics has raised a total of $48.5m in funding over 3 rounds.
Key Insights:
- Magenta Therapeutics Series A round, November 2016: $48.5m
- Magenta Therapeutics funding round, May 2017: $50m
- Magenta Therapeutics funding round, April 2018: $52m
Magenta Therapeutics Series A round, November 2016
$48.5m
Magenta Therapeutics funding round, May 2017
$50m
Magenta Therapeutics funding round, April 2018
$52m
Industries
Magenta Therapeutics is active in the following industries: